Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation - PubMed (original) (raw)
. 2002 Dec 12;21(57):8852-61.
doi: 10.1038/sj.onc.1206048.
Affiliations
- PMID: 12483537
- DOI: 10.1038/sj.onc.1206048
Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation
Asok Mukhopadhyay et al. Oncogene. 2002.
Abstract
Cyclin D1 is a proto-oncogene that is overexpressed in many cancers including breast and prostate. It plays a role in cell proliferation through activation of cyclin-dependent kinases. Curcumin, a diferuloylmethane, is a chemopreventive agent known to inhibit the proliferation of several breast and prostate cancer cell lines. It is possible that the effect of curcumin is mediated through the regulation of cyclin D1. In the present report we show that inhibition of the proliferation of various prostate, breast and squamous cell carcinoma cell lines by curcumin correlated with the down-regulation of the expression of cyclin D1 protein. In comparison, the down-regulation by curcumin of cyclin D2 and cyclin D3 was found only in selective cell lines. The suppression of cyclin D1 by curcumin led to inhibition of CDK4-mediated phosphorylation of retinoblastoma protein. We found that curcumin-induced down-regulation of cyclin D1 was inhibited by lactacystin, an inhibitor of 26S proteosome, suggesting that curcumin represses cyclin D1 expression by promoting proteolysis. We found that curcumin also down-regulated mRNA expression, thus suggesting transcriptional regulation. Curcumin also inhibited the activity of the cyclin D1 promoter-dependent reporter gene expression. Overall our results suggest that curcumin down-regulates cyclin D1 expression through activation of both transcriptional and post-transcriptional mechanisms, and this may contribute to the antiproliferative effects of curcumin against various cell types.
Similar articles
- Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
Srethapakdi M, Liu F, Tavorath R, Rosen N. Srethapakdi M, et al. Cancer Res. 2000 Jul 15;60(14):3940-6. Cancer Res. 2000. PMID: 10919672 - GL331 induces down-regulation of cyclin D1 expression via enhanced proteolysis and repressed transcription.
Lin S, Huang HC, Chen LL, Lee CC, Huang TS. Lin S, et al. Mol Pharmacol. 2001 Oct;60(4):768-75. Mol Pharmacol. 2001. PMID: 11562439 - Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH. Chinni SR, et al. Oncogene. 2001 May 24;20(23):2927-36. doi: 10.1038/sj.onc.1204365. Oncogene. 2001. PMID: 11420705 - Examining the role of cyclin D1 in breast cancer.
Velasco-Velázquez MA, Li Z, Casimiro M, Loro E, Homsi N, Pestell RG. Velasco-Velázquez MA, et al. Future Oncol. 2011 Jun;7(6):753-65. doi: 10.2217/fon.11.56. Future Oncol. 2011. PMID: 21675838 Review. - CDK-independent activities of D type cyclins.
Bernards R. Bernards R. Biochim Biophys Acta. 1999 Oct 29;1424(2-3):M17-22. doi: 10.1016/s0304-419x(99)00024-4. Biochim Biophys Acta. 1999. PMID: 10528151 Review. No abstract available.
Cited by
- Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane).
Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung B, Sethi G, Aggarwal BB. Sandur SK, et al. Free Radic Biol Med. 2007 Aug 15;43(4):568-80. doi: 10.1016/j.freeradbiomed.2007.05.009. Epub 2007 May 16. Free Radic Biol Med. 2007. PMID: 17640567 Free PMC article. - Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma.
Sager RA, Backe SJ, Ahanin E, Smith G, Nsouli I, Woodford MR, Bratslavsky G, Bourboulia D, Mollapour M. Sager RA, et al. Nat Rev Urol. 2022 May;19(5):305-320. doi: 10.1038/s41585-022-00571-8. Epub 2022 Mar 9. Nat Rev Urol. 2022. PMID: 35264774 Free PMC article. Review. - Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update.
Hatzimichael E, Lagos K, Sim VR, Briasoulis E, Crook T. Hatzimichael E, et al. EXCLI J. 2014 Aug 26;13:954-76. eCollection 2014. EXCLI J. 2014. PMID: 26417314 Free PMC article. Review. - An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
Sahafnejad Z, Ramazi S, Allahverdi A. Sahafnejad Z, et al. Genes (Basel). 2023 Apr 6;14(4):873. doi: 10.3390/genes14040873. Genes (Basel). 2023. PMID: 37107631 Free PMC article. Review. - MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells.
Liang HH, Wei PL, Hung CS, Wu CT, Wang W, Huang MT, Chang YJ. Liang HH, et al. Tumour Biol. 2013 Oct;34(5):3209-18. doi: 10.1007/s13277-013-0891-z. Epub 2013 Jun 13. Tumour Biol. 2013. PMID: 23760980
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials